Cancer Eye (ocular SCC)

Cancer eye, scientifically known as ocular squamous cell carcinoma, represents the most common neoplastic condition affecting cattle worldwide and constitutes a significant cause of economic loss and animal welfare concerns in the beef and dairy industries. This malignant tumor arises from the squamous epithelial cells of the eye and surrounding structures, including the eyelids, third eyelid, conjunctiva, and cornea. The condition typically begins as benign precursor lesions that progress through increasingly severe stages, ultimately developing into invasive carcinomas capable of destroying ocular tissues and metastasizing to regional lymph nodes and distant organs.

Ocular squamous cell carcinoma affects cattle of all breeds and production types, though prevalence varies dramatically based on genetic factors, geographic location, and environmental exposure patterns. The disease occurs worldwide but is particularly problematic in regions with high solar radiation intensity, including tropical and subtropical climates and high-altitude environments. Studies indicate that cancer eye affects between two and ten percent of susceptible cattle populations, with some herds experiencing much higher rates when risk factors converge. The condition typically manifests in adult cattle, with peak incidence occurring between seven and nine years of age.

The economic impact of cancer eye extends beyond direct treatment costs to include lost production, reduced carcass value, condemnation at slaughter, and premature culling of valuable breeding animals. Affected cattle may experience pain and distress as tumors grow, leading to decreased feed intake, reduced weight gain, and impaired reproductive performance. Animals with visible tumors face marketing challenges, as they may be rejected at sale barns or receive significant price discounts. Regulatory condemnation of carcasses with metastatic disease represents a complete loss of meat value. These combined factors make cancer eye one of the most economically significant diseases affecting cattle in endemic regions.

Early detection and prompt treatment of cancer eye dramatically improve outcomes and provide the best opportunity for preserving the affected eye and the animal's productive life. Precancerous lesions and early-stage tumors respond well to various treatment modalities, with cure rates exceeding eighty percent when intervention occurs before invasion of deeper tissues. Regular examination of cattle, particularly those with known risk factors, enables identification of lesions at treatable stages. Understanding the risk factors, clinical progression, and treatment options for cancer eye empowers producers to implement effective prevention and management strategies that minimize losses from this condition.

The primary cause of ocular squamous cell carcinoma in cattle is chronic exposure to ultraviolet radiation from sunlight, which induces cumulative DNA damage in the susceptible epithelial cells of the eye and periocular tissues. Ultraviolet B radiation is particularly carcinogenic, causing direct DNA damage through the formation of pyrimidine dimers that can lead to mutations in tumor suppressor genes and oncogenes. The cumulative nature of this damage explains why cancer eye primarily affects older cattle that have experienced years of solar exposure. Environmental factors that increase UV exposure, including high altitude, low latitude, lack of shade, and extended daylight hours, all correlate with increased cancer eye incidence.

Genetic predisposition plays a crucial role in cancer eye susceptibility, with lack of periocular pigmentation representing the single most important risk factor. Cattle with white faces, unpigmented eyelids, and lack of dark coloring around the eyes experience dramatically higher rates of ocular squamous cell carcinoma than those with pigmented periocular skin. The protective melanin pigment in dark-skinned cattle absorbs ultraviolet radiation before it can damage underlying epithelial cells. Heritability studies confirm that periocular pigmentation is a polygenic trait that responds to selection, enabling producers to reduce cancer eye incidence through genetic management. Beyond pigmentation, other genetic factors may influence susceptibility to UV-induced carcinogenesis, though these are less well characterized.

Environmental and management factors beyond UV exposure contribute to cancer eye development and progression. Dust, wind, and irritating plant materials can cause chronic ocular irritation that promotes cellular proliferation and increases vulnerability to carcinogenic transformation. Infectious agents, including bovine papillomavirus and bovine herpesvirus, have been implicated in some cases of ocular squamous cell carcinoma, potentially acting as cofactors with UV radiation. Nutritional factors, particularly deficiencies in vitamin A and other antioxidants, may impair cellular defenses against oxidative damage. Concurrent eye diseases or injuries that cause chronic inflammation may predispose affected tissues to malignant transformation.

Risk factors for cancer eye include both inherent characteristics and environmental exposures that can be modified through management. Age represents a major risk factor, with incidence increasing progressively in cattle over five years old and peaking between seven and nine years. Geographic location influences risk through both UV intensity and local vegetation that may cause ocular irritation. Management systems that keep cattle in open pastures without shade increase UV exposure compared to those providing tree cover, shelters, or housed management. Genetic risk relates primarily to breed and individual pigmentation patterns, with selection for pigmented periocular skin representing the most effective long-term risk reduction strategy.

The pathophysiology of ocular squamous cell carcinoma involves a multistep progression from normal epithelium through precancerous changes to invasive carcinoma. Initial UV damage causes epithelial hyperplasia and keratinization, visible as thickened, rough-surfaced plaques on affected structures. Continued damage leads to dysplasia, characterized by abnormal cellular architecture and nuclear changes, representing a precancerous state. Carcinoma in situ develops when malignant cellular changes affect the full thickness of the epithelium but have not invaded the underlying basement membrane. Invasive carcinoma occurs when malignant cells breach the basement membrane and begin infiltrating underlying tissues. Advanced tumors may invade the orbit, extend into the brain, or metastasize to regional lymph nodes and distant sites.

Early warning signs of cancer eye often begin as subtle changes in the appearance of the periocular tissues that may be overlooked during routine observations. Initial lesions typically appear as small, raised, pink or white plaques on the eyelid margins, third eyelid, conjunctiva, or limbus at the junction of the cornea and sclera. These early lesions may be smooth or slightly roughened and often measure less than one centimeter in diameter. Affected cattle may show mild signs of ocular discomfort, including increased blinking, slight tearing, or rubbing of the eye against objects or legs. Early lesions are frequently mistaken for minor injuries or inflammatory conditions, leading to delayed diagnosis and treatment.

Common symptoms of established cancer eye vary depending on the location and size of the tumor but typically include visible tumor growth, ocular discharge, and progressive tissue destruction. Tumors on the eyelids appear as raised, irregular masses that may ulcerate and bleed. Third eyelid lesions present as pink to red, cauliflower-like growths visible at the medial canthus when the third eyelid protrudes. Corneal tumors cause opacity and vascularization of the normally clear cornea. Excessive tearing, ranging from clear fluid to blood-tinged or purulent discharge, commonly accompanies tumor growth. An unpleasant odor may develop as tumors become necrotic and secondarily infected.

Behavioral changes associated with cancer eye reflect the progressive pain and visual impairment caused by growing tumors. Affected cattle may shake their heads frequently, rub the affected eye against fences or other objects, and show increased sensitivity to bright light. Animals with significant tumors often become reluctant to move, particularly in unfamiliar environments, and may startle easily due to reduced visual awareness on the affected side. Feed intake may decline as pain and discomfort interfere with normal grazing behavior. Social interactions may change, with affected animals spending more time isolated from herd mates or becoming more defensive about approach to their affected side.

Physical signs of advanced cancer eye become increasingly dramatic and disturbing as tumors grow and invade surrounding structures. Large tumors may protrude from the eye socket as fungating, hemorrhagic masses that bleed freely when traumatized. Destruction of the eyelids eliminates protection for the cornea, which becomes dried, ulcerated, and opaque. Orbital invasion causes the eye to become displaced or fixed in an abnormal position. Secondary infections produce purulent discharge and foul odor. Facial swelling may indicate involvement of periorbital tissues or regional lymph nodes. Emaciation develops in severely affected animals due to chronic pain, infection, and reduced feed intake.

Symptom progression in cancer eye follows a predictable pattern from precancerous plaques through invasive carcinoma, though the rate of progression varies considerably between individual animals. Plaques may remain stable for months to years before progressing to papillomas, which are raised, roughened lesions with irregular surfaces. Papillomas typically transform to carcinomas over a period of months, becoming more vascular, more friable, and increasingly invasive. Once invasion begins, tumors generally grow more rapidly and become more difficult to treat. The total duration from initial plaque to advanced carcinoma typically spans one to three years but may be shorter in rapidly progressing cases.

Emergency symptoms requiring immediate veterinary attention include rapidly growing or bleeding tumors, complete loss of vision, severe swelling of the orbital region, evidence of systemic illness such as fever or depression, and any indication of tumor spread beyond the primary site. Animals with tumors that have invaded the orbit or extended behind the eye require urgent evaluation for treatment options versus humane euthanasia. Cattle showing signs of chronic uncontrolled pain, including persistent head shaking, grinding of teeth, or severe depression, need immediate assessment and pain management. Any animal that has lost the ability to eat, drink, or maintain body condition due to cancer eye requires prompt veterinary intervention.

Clinical examination for cancer eye begins with careful visual inspection of both eyes and surrounding structures in adequate lighting, ideally with the animal properly restrained for safety and thorough evaluation. The examiner systematically evaluates the eyelids, third eyelid, conjunctiva, cornea, and sclera of each eye, noting any abnormalities in color, surface texture, or contour. The third eyelid should be manually elevated or allowed to protrude using gentle pressure on the globe through the upper lid to enable complete visualization. Palpation of regional lymph nodes, particularly the parotid and mandibular nodes, assesses for evidence of metastatic spread. A staging system categorizes lesions based on size, location, and invasiveness to guide treatment decisions and prognosis.

Diagnostic tests for cancer eye primarily rely on visual examination and biopsy, with additional procedures reserved for specific clinical questions. Biopsy with histopathological examination provides definitive diagnosis and differentiates between precancerous lesions, carcinoma in situ, and invasive carcinoma. Fine needle aspirate cytology of enlarged lymph nodes evaluates for metastatic disease. Radiography or ultrasonography of the orbit may assess the depth of invasion in advanced tumors. Complete blood count and serum chemistry panels evaluate overall health status and detect abnormalities that might indicate systemic disease. Bacterial culture and sensitivity testing guide antibiotic selection when secondary infections complicate tumor management.

Differential diagnosis for ocular and periocular masses in cattle includes several conditions that may resemble squamous cell carcinoma on gross examination. Papillomas caused by bovine papillomavirus typically affect younger cattle and have a characteristic cauliflower-like appearance but are benign and often regress spontaneously. Dermoids are congenital lesions containing hair and skin elements that may occur on the cornea or conjunctiva. Granulation tissue from previous injuries or chronic inflammation can form raised, vascular masses. Lymphoma may affect ocular structures and appears as diffuse enlargement rather than discrete tumors. Infectious conditions including infectious bovine keratoconjunctivitis and foreign bodies must be distinguished from neoplasia.

Herd-level diagnostic approaches for cancer eye focus on identifying prevalence rates and risk factors to guide prevention programs. Regular examination of all cattle in the herd, ideally performed during routine handling for other procedures, enables early detection and monitoring of lesion progression. Recording the number, location, and stage of lesions across the herd population provides data for evaluating management interventions. Analysis of culling records for cancer eye as a reason for removal tracks disease impact over time. Evaluation of sire and dam breeding values for periocular pigmentation supports genetic selection decisions. Comparison of cancer eye rates across management groups helps identify environmental or management factors contributing to disease incidence.

Emergency treatment for cattle with severely advanced or acutely complicated cancer eye focuses on immediate pain management and assessment of treatment feasibility versus humane euthanasia. Animals with large, bleeding tumors require hemostasis through direct pressure, cautery, or ligation of feeding vessels when accessible. Pain management using non-steroidal anti-inflammatory drugs or local anesthesia provides immediate relief while treatment decisions are made. Fly control prevents further irritation and maggot infestation of open tumors. Animals in severe distress with no reasonable prospect of effective treatment should be humanely euthanized to prevent continued suffering. Food safety considerations require attention to withdrawal times for any medications administered to cattle destined for slaughter.

Medical management options for cancer eye include local treatments applied directly to tumors and systemic approaches that support the animal's immune response. Topical chemotherapy using five-fluorouracil or mitomycin C can effectively treat superficial lesions and early-stage tumors. Immunotherapy with BCG vaccine or other immune stimulants injected directly into tumors activates the animal's immune system against cancer cells and has demonstrated efficacy for moderate-sized lesions. Radiation therapy, where available, provides effective local control for tumors in challenging locations. Systemic anti-inflammatory medication reduces pain and tumor-associated inflammation. All treatments require attention to meat and milk withdrawal times as applicable.

Surgical options represent the most commonly employed treatments for cancer eye and range from simple excision to complete enucleation depending on tumor extent. Excisional surgery removes the tumor along with a margin of normal tissue and is appropriate for small, well-defined lesions that can be completely excised without sacrificing the eye. Cryosurgery using liquid nitrogen destroys tumor tissue through freezing and is effective for superficial lesions and as an adjunct to excision. Radiofrequency hyperthermia heats tumor tissue to lethal temperatures and works well for accessible lesions. Enucleation, the complete removal of the eye and surrounding tissues, is necessary for tumors that have invaded the orbit or cannot be controlled with eye-sparing approaches. Exenteration involves removing the entire orbital contents including periorbital tissues and is indicated for extensive local invasion.

Supportive care for cattle undergoing treatment for cancer eye emphasizes wound management, pain control, and nutritional support during recovery. Surgical sites require protection from contamination, flies, and self-trauma during the healing period. Systemic antibiotics prevent or treat secondary infections of surgical wounds or ulcerated tumors. Adequate nutrition maintains immune function and supports tissue healing. Eye protection devices or housing modifications may protect treated eyes during recovery. Regular monitoring enables early detection of complications or tumor recurrence.

Herd treatment protocols for cancer eye focus on systematic examination, early intervention, and genetic management rather than treatment of individual cases in isolation. Regular screening of all cattle identifies lesions at treatable stages when cure rates are highest. Treatment protocols standardize the approach to lesions of different stages, ensuring consistent and effective management. Records of affected animals, lesion characteristics, treatments applied, and outcomes support continuous improvement of herd health programs. Genetic evaluation identifies high-risk bloodlines for selection or culling decisions.

Treatment decisions for cancer eye must balance animal welfare, treatment costs, prognosis, and the animal's production value. Small, early-stage lesions in valuable breeding animals justify aggressive treatment with good expectations for cure and continued productive life. Large, invasive tumors carry poor prognoses regardless of treatment approach, making salvage slaughter or humane euthanasia more appropriate options. Animals approaching the end of their productive lives may be best served by monitoring and salvage slaughter before tumors become too advanced for carcass acceptance. The cost of treatment must be weighed against the animal's value and the likelihood of success, with economic analysis often supporting early intervention in valuable animals and prompt culling in commercial cattle with advanced disease.

Recovery timeline following treatment for cancer eye varies considerably depending on the treatment modality employed and the extent of disease at the time of intervention. Simple excision of small tumors typically heals within two to four weeks, with most animals returning to normal function promptly. Cryosurgery produces tissue necrosis and sloughing over ten to twenty-one days, followed by granulation and epithelialization over several additional weeks. Enucleation sites generally heal within three to four weeks, though complete adaptation to monocular vision may take longer. Immunotherapy protocols typically require multiple treatment sessions over several weeks to months, with tumor regression occurring gradually during this period.

Post-treatment care and monitoring for cattle recovering from cancer eye treatment emphasize wound protection, infection prevention, and early detection of recurrence. Surgical sites require daily observation for signs of infection, excessive swelling, or dehiscence. Fly control is essential during the healing period to prevent myiasis and reduce irritation. Protection from dust and direct sunlight supports healing and reduces discomfort. Follow-up examinations at regular intervals assess healing progress and identify any evidence of tumor recurrence or new lesion development. The opposite eye should be monitored carefully, as bilateral disease occurs in a significant proportion of affected animals.

Prognosis for cancer eye depends primarily on the stage of disease at the time of treatment, with early intervention dramatically improving outcomes. Precancerous plaques and papillomas treated appropriately have cure rates exceeding ninety percent. Carcinoma in situ responds well to various treatments with cure rates of eighty to ninety percent. Invasive carcinomas that have not extended beyond local tissues have cure rates of sixty to eighty percent with appropriate surgery. Tumors that have invaded the orbit carry guarded prognoses, with cure rates of forty to sixty percent following exenteration. Animals with lymph node metastasis have poor prognoses, and distant metastasis is generally considered incurable.

Return to production considerations following cancer eye treatment include both physical recovery and assessment of future risk. Animals that retain vision in the affected eye can generally return to normal production activities once healing is complete. Cattle that have undergone enucleation adapt remarkably well to monocular vision and can continue productive lives with appropriate management considerations. Breeding animals should be evaluated for the genetic contribution to cancer eye risk before continuing in the breeding herd. Treated animals remain at elevated risk for recurrence at the original site and for development of new lesions, necessitating ongoing monitoring throughout their productive lives. Marketing considerations may affect the optimal timing for sale of recovered animals.

Vaccination protocols play no direct role in cancer eye prevention, as no vaccines exist that prevent squamous cell carcinoma in cattle. However, research into therapeutic cancer vaccines and immunotherapy continues, with some promising results for treatment applications. Vaccination against bovine papillomavirus has been investigated as a potential preventive strategy given the virus's suspected role in some cases, though this approach remains experimental. The absence of effective vaccination options emphasizes the critical importance of genetic selection and management-based prevention strategies for reducing cancer eye incidence in cattle populations.

Biosecurity measures have limited relevance for cancer eye prevention since the condition is not contagious and does not spread between animals through contact or environmental contamination. However, sourcing cattle from herds with low cancer eye incidence and selecting animals with appropriate pigmentation characteristics represents a form of genetic biosecurity that prevents introduction of high-risk genetics. Maintaining records of cancer eye history when purchasing breeding stock helps avoid introducing susceptible bloodlines. Awareness of the cancer eye status of bulls used for natural service or artificial insemination supports informed breeding decisions.

Nutritional prevention strategies for cancer eye focus on supporting overall health and potentially reducing oxidative stress that may contribute to carcinogenesis. Adequate vitamin A nutrition maintains healthy epithelial tissues and supports immune function. Antioxidant supplementation, including vitamin E and selenium, may reduce cellular damage from UV-induced oxidative stress, though direct evidence for cancer eye prevention is limited. Avoiding nutritional deficiencies that could impair immune function or tissue integrity represents a prudent approach to overall disease prevention. Maintaining appropriate body condition supports the animal's natural defenses against all disease processes.

Management practices offer the most practical opportunities for reducing cancer eye incidence beyond genetic selection. Providing shade in pastures reduces cumulative UV exposure and has been shown to decrease cancer eye rates in at-risk populations. Timing intensive management activities to avoid peak UV hours limits acute exposure. Managing cattle in regions with lower UV intensity, where practical, reduces lifetime exposure. Avoiding irritating dust and plant materials through pasture management reduces ocular trauma that may contribute to cancer development. Regular herd examination enables early detection and treatment when lesions are most responsive.

Quarantine and testing protocols for cancer eye relate primarily to pre-purchase examination and genetic evaluation rather than infectious disease control. All cattle should be carefully examined for ocular lesions before purchase, with affected animals either rejected or priced accordingly. Documentation of periocular pigmentation patterns supports selection decisions. Testing for inherited factors influencing cancer eye susceptibility may become more practical as genetic markers are identified. Herd-level monitoring programs track disease incidence over time and evaluate the effectiveness of prevention strategies. Coordination with breed associations and genetic evaluation programs supports industry-wide efforts to reduce cancer eye prevalence through genetic improvement.

Daily management and monitoring for herds affected by cancer eye requires systematic observation of all animals with particular attention to those with known risk factors. During routine cattle handling, each animal's eyes should be briefly examined for any abnormalities in appearance. Animals previously treated for cancer eye require more frequent and detailed examination to detect recurrence early. Any animal showing behavioral signs suggestive of ocular discomfort, such as excessive blinking, tearing, or head rubbing, should be caught and examined more thoroughly. Documentation of findings enables tracking of lesion progression and treatment outcomes. Training all personnel who handle cattle to recognize early signs of cancer eye maximizes detection sensitivity.

Housing and environmental management strategies for cancer eye prevention focus on reducing UV exposure and ocular irritation. Providing adequate shade in pastures, either through natural tree cover or constructed shelters, allows cattle to escape direct sunlight during peak UV hours. Positioning water sources, feeding areas, and mineral stations in shaded locations encourages cattle to spend time out of direct sun. Managing pastures to reduce dust and avoiding grazing in areas with irritating plant species decreases ocular trauma. Housing options for intensively managed cattle should include appropriate lighting and ventilation to maintain eye health. Penning or paddocking of animals with advanced lesions prevents injury to tumors and facilitates treatment and monitoring.

Herd health programs addressing cancer eye integrate genetic selection, environmental management, and early detection into comprehensive control strategies. Breeding programs should prioritize periocular pigmentation in their selection criteria, using visual evaluation and potentially genomic testing to improve pigmentation over generations. Environmental modifications to reduce UV exposure should be implemented based on assessment of available shade and management patterns. Regular herd screening identifies affected animals early when treatment is most effective. Culling protocols establish criteria for removal of affected animals based on lesion stage, treatment response, and genetic value. Economic analysis of control program costs and benefits guides resource allocation decisions.

Record keeping and monitoring systems for cancer eye track disease incidence, individual animal histories, and the effectiveness of control measures. Individual animal records should include pigmentation scores, any lesions detected, treatments administered, and outcomes. Herd-level records track the number of affected animals, stage distribution of lesions, treatment costs, and culling losses. Analysis of affected animal characteristics identifies risk factors specific to the herd. Evaluation of offspring from affected versus unaffected parents assesses heritability and guides selection decisions. Regular reporting to herd veterinarians enables professional oversight and program refinement.

Economic considerations for cancer eye management influence decisions at both the individual animal and herd levels. The cost of regular screening programs is generally modest and is offset by the value of early detection. Treatment costs vary widely depending on the modality employed and the stage of disease, ranging from minimal for simple cryosurgery to substantial for repeated immunotherapy or enucleation. Lost production value from affected animals includes reduced weight gain, decreased milk production, and premature culling. Carcass condemnation for metastatic disease represents complete loss of meat value. Investment in genetic improvement through selection for pigmentation provides long-term returns through reduced disease incidence in future generations.

High-risk breeds for cancer eye are those characterized by white faces and lack of periocular pigmentation, with Hereford cattle representing the classic example of a highly susceptible breed. The Hereford breed's characteristic white face with minimal eyelid pigmentation creates ideal conditions for UV-induced carcinogenesis. Simmental cattle, which often have light-colored faces with unpigmented periocular skin, also experience elevated cancer eye rates. Other white-faced breeds and crossbreds, including Charolais crosses, white Shorthorns, and various composite breeds incorporating Hereford genetics, may show increased susceptibility depending on individual pigmentation patterns. Even within high-risk breeds, individual variation in pigmentation creates a spectrum of susceptibility that enables selection for more resistant phenotypes.

Production type considerations influence both cancer eye prevalence and management approaches in affected herds. Beef cattle maintained on extensive range operations experience high cumulative UV exposure over long productive lives, creating conditions for cancer eye development. Dairy breeds with light coloring around the eyes, particularly Holstein cattle with white facial markings extending to the periocular region, face elevated risk despite typically shorter productive lives. Show cattle may experience additional risk from preparation procedures and travel stress. Seedstock operations must balance selection for production traits against the need to address cancer eye susceptibility in their genetic programs. Commercial operations can reduce cancer eye incidence through terminal crossing with heavily pigmented sire breeds.

Genetic selection and testing represent the most effective long-term strategies for reducing cancer eye incidence within susceptible breeds. Visual evaluation of periocular pigmentation should be a standard component of breeding animal selection, with heavily pigmented individuals preferred over those with minimal pigmentation. Expected progeny differences and genomic predictions for pigmentation traits, where available, enable more accurate selection decisions. Culling policies should consider cancer eye history when evaluating breeding animals, with affected individuals and their close relatives receiving scrutiny. Crossbreeding programs utilizing heavily pigmented breeds such as Angus can dramatically reduce cancer eye incidence in subsequent generations while maintaining other desirable characteristics.

Commonly co-occurring conditions with cancer eye include other manifestations of UV-induced skin damage and conditions related to chronic ocular irritation or immune dysfunction. Squamous cell carcinoma may occur at other anatomic sites exposed to solar radiation, including the vulva, perineum, and non-pigmented skin areas. Chronic keratitis and corneal scarring may result from long-term UV exposure and chronic irritation in the same animals predisposed to cancer eye. Infectious bovine keratoconjunctivitis occurs frequently in cattle populations and may create ocular inflammation that predisposes to neoplastic transformation. Secondary bacterial infections commonly complicate cancer eye lesions, requiring antimicrobial treatment alongside tumor management.

Conditions with similar symptoms that must be differentiated from cancer eye include various causes of ocular masses and chronic eye irritation in cattle. Bovine papillomatosis produces wart-like growths that may affect the periocular region and can resemble early cancer eye lesions. Granulation tissue from previous injuries or chronic inflammation forms raised, vascular tissue that may be mistaken for early tumors. Dermoid cysts are congenital lesions containing hair and skin elements that may occur on the cornea or conjunctiva. Foreign bodies embedded in ocular tissues can cause chronic irritation and granulation tissue formation. Lymphoma occasionally affects ocular structures and may present as ocular masses requiring differentiation from squamous cell carcinoma.

Complications and sequelae of cancer eye extend beyond local tumor effects to include systemic consequences of advanced disease. Orbital invasion destroys the normal anatomy of the eye socket and may extend to involve the brain in severe cases. Metastasis to regional lymph nodes, particularly the parotid and retropharyngeal nodes, indicates systemic spread and worsens prognosis. Distant metastasis to lungs, liver, and other organs occurs in a small percentage of advanced cases. Chronic pain and infection lead to decreased feed intake, weight loss, and general debilitation. Secondary bacterial infections of ulcerated tumors may cause septicemia in severely affected animals. Bilateral disease affecting both eyes significantly impairs quality of life and usually necessitates culling or euthanasia.